Archives
-
Bifendate, Autophagy, and Lipid Droplet Accumulation
2026-10-02
The reference study shows that bifendate inhibits autophagy at several lysosome-related checkpoints rather than at a single stage, while also reducing oleic acid-induced lipid droplet accumulation in cultured cells. Its layered experimental design provides a useful framework for connecting autophagic flux, lysosomal function, and hepatic lipid-storage phenotypes.
-
DAPT (GSI-IX) in Human Neuron Models
2026-10-01
DAPT (GSI-IX) offers translational researchers a defined way to perturb γ-secretase-dependent APP processing and Notch signaling in disease-relevant systems, including scalable human sensory neuron models for mechanistic studies of latency, reactivation, and cell fate.
-
Pregnenolone Carbonitrile: Practical Research Workflows
2026-10-01
Pregnenolone Carbonitrile provides a controlled way to interrogate rodent PXR-driven xenobiotic metabolism while also enabling liver fibrosis and tissue-specific CYP studies. Its value is greatest when hepatic induction is separated from hippocampal, glucocorticoid receptor-linked suppression rather than treated as a universal response.
-
NF 449: From Receptor Signal to Thrombus Phenotype
2026-09-30
NF 449 is a potent purinergic receptor antagonist for tracing P2X1-dependent platelet signaling. This article presents a phenotype-to-receptor framework that connects calcium influx, collagen-induced platelet aggregation, and thrombus biology while clarifying dose-dependent selectivity.
-
Filipin III: From Cholesterol Maps to Fibrosis
2026-09-30
Filipin III offers a mechanistically informative view of accessible cholesterol in membranes, creating a bridge between membrane biophysics and translational studies of lipid-driven disease. This article examines how cholesterol imaging could extend recent findings on SOAT1, lipophagy, and PHMG-induced pulmonary fibrosis while defining the probe’s practical strengths, limitations, and validation path.
-
Naftifine HCl: Mechanism-First Assay Design
2026-09-29
Naftifine HCl is an allylamine antifungal agent whose sterol-biosynthesis mechanism can be investigated through coordinated biochemical, cellular, and phenotypic assays. This article uses the WNT5a/GSK3/β-catenin study as a methodological framework while clearly separating antifungal evidence from cross-domain interpretation.
-
β-Galactosidase Reporter Assay Kit Workflow
2026-09-29
Convert promoter design into quantitative evidence with a β-galactosidase workflow built for side-by-side testing in Escherichia coli and Saccharomyces cerevisiae. The approach separates host effects, expression strength, and assay artifacts so hybrid promoters can be ranked before they are deployed in metabolic pathways.
-
Cepharanthine in Endometriosis: Organoids and In Vivo
2026-09-28
A 2026 study evaluates Cepharanthine across immortalized stromal cells, patient-derived endometriotic cells, endometrial organoids, and a murine peritoneal model. Its central contribution is the convergence of reduced lesion growth with G0/G1 arrest, DNA damage, impaired repair, and mitochondria-associated apoptosis, while also identifying important limitations for clinical translation.
-
Cdc42 Inhibition: A Translational Lens on Fibrosis
2026-09-28
A recent kidney-fibrosis study puts Cdc42 in a consequential disease pathway. This article examines what that evidence does—and does not—establish for ZCL278, and how researchers can use selective Cdc42 inhibition to build a more rigorous translational case.
-
JNJ-10198409 for PDGF Receptor Assay Design
2026-09-27
Use JNJ-10198409 to separate acute PDGF receptor signaling from later proliferation and migration phenotypes in cell-based studies. A time-resolved workflow, informed by recent host-signaling research but carefully bounded to mammalian PDGF biology, helps distinguish target engagement from downstream effects.
-
4-Ethylphenyl Sulfate in Cell Assay Design
2026-09-26
A scenario-based guide to using 4-ethylphenyl sulfate (SKU B6051) in cell-based research without mistaking a test compound for an assay reagent. It covers stock preparation, vehicle controls, renal-toxin context, interpretation limits, and practical product-selection criteria.
-
Annexin V Workflows for Apoptosis Detection
2026-09-25
Use recombinant Annexin V to detect exposed phosphatidylserine and map cell-death responses by flow cytometry or fluorescence microscopy. This guide explains how to work with an unlabeled reagent, build practical assay controls, and troubleshoot calcium-dependent binding.
-
Senescent CAFs Suppress NK Cells in Breast Cancer
2026-09-25
Ye and colleagues identify senescent myofibroblast cancer-associated fibroblasts as a tumor-promoting population in breast cancer, linking their extracellular matrix to reduced natural killer cell cytotoxicity. The work combines inducible cell depletion in a mouse model with human tumor analyses, supporting senCAF biology as a potential therapeutic and prognostic research direction while leaving questions about cell specificity and clinical causality open.
-
PBS Liposomes: Controls Across Experimental Scales
2026-09-24
PBS Liposomes provide a negative control for interpreting macrophage depletion, but their value depends on matching the experimental question to the control. This article connects that control logic to structural evidence on TRPM3 while clarifying what the two experimental domains do—and do not—establish.
-
FLAG tag Peptide for Exosome Pathway Studies
2026-09-24
Use the FLAG tag Peptide (DYKDDDDK) to recover tagged pathway proteins with competitive, generally gentle affinity elution—not to isolate intact exosomes. This practical guide connects RAB31 pathway questions to a protein purification workflow, with pilot conditions and troubleshooting for tagged-protein studies.